Novel mechanism of P-fimbriated Escherichia coli virulence in pyelonephritis

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3458-3460

  Stapleton, Ann ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CERAMIDE; CYTOLYSIN; CYTOTOXIC NECROTIZING FACTOR 1; FIMBRIA PROTEIN; LIPOPOLYSACCHARIDE; SECRETORY COMPONENT; TOLL LIKE RECEPTOR 4;

BACTERIAL VIRULENCE; CYSTITIS; EDITORIAL; FIMBRIA; HUMAN; IMMUNE RESPONSE; INCIDENCE; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PYELONEPHRITIS; RISK ASSESSMENT; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; NOTE; PARASITOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE, BACTERIAL; MICE; PYELONEPHRITIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VIRULENCE;

EID: 33645927047     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101045     Document Type: Editorial

References (28)

1. Ronald A: Editorial comment: Sexually transmitted diseases and urinary tract infections. Cur Open Infect Dies 8: 1-3, 1995
2. Stamm WE. Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and prevention. Am J Med 91[Suppl 3B]: 3B-65S-3B-71S, 1991
3. Bergeron M: Treatment of pyelonephritis in adults. Med Clin N Am 79: 619-649, 1995
4. Stapleton A: Urinary tract infections in patients with diabetes. Am J Med 113[Suppl 1A]: 80S-84S, 2002
5. Hooton T: The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 17: 303-332, 2003
6. Johnson J: Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 17: 261-278, viii, 2003
7. Oelschlaeger TA, Dobrindt U, Hacker J: Virulence factors of uropathogens. Curr Opin Urol 12: 33-38, 2002
8. Emody L, Kerenyi M and Nagy G: Virulence factors of uropathogenic Escherichia coli. Int J Antimicrob Agents 22[Suppl 2]: 29-33, 2003
9. Kallenius G, Mollby R, Svenson SB, Helin I, Hultberg H, Cedergren B, Winberg J: Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet 2: 1369-1372, 1981
10. Johnson JR: papG alleles among Escherichia coli strains causing urosepsis: Associations with other bacterial characteristics and host compromise. Infect Immun 66: 4568-4571, 1998
11. Roberts AP, Phillips R: Bacteria causing symptomatic urinary tract infection or asymptomatic bacteriuria. J Clin Pathol 32: 492-496, 1979
12. Winberg J, Mollby R, Bergstrom J, Karlsson KA, Leonardsson I, Milh MA, Teneberg S, Haslam D, Marklund BI, Normark S: The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of cynomolgus monkeys. J Exp Med 182: 1695-1702, 1995
13. Wullt B, Bergsten G, Connell H, Rollano P, Gebretsadik N, Hull R, Svanborg C: P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 38: 456-464, 2000
14. Kallenius G, Mollby R, Svenson SB, Winberg J, Hultberg H: Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection 8[Suppl 3]: S288-S293, 1981
15. Kallenius G, Mollby R, Svenson SB, Winberg J, Lundblad A, Svensson S, Cedergren B: The Pk antigen as receptor for the haemagglutinin of pyelonephritic Escherichia coli. FEMS Microbiol Lett 7: 297-302, 1980
16. Kallenius G, Svenson SB, Mollby R, Cedergren B, Hultberg H, Winberg J: Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet 2: 604-606, 1981
17. Svanborg-Eden C, Leffler H: Glycosphingolipids of human urinary tract epithelial cells as possible receptors for adhering Escherichia coli. Scand J Infect Dis 24: 144-147, 1980
18. Holgersson J, Jovall P-A, Samuelsson BE, Breimer ME: Structural characterization of non-acid glycosphingolipids in kidneys of single blood group O and A pigs. J Biochem 108: 766-777, 1990
19. Holgersson J, Jovall P-A, Samuelsson BE, Breimer ME: Blood group glycosphingolipids in human kidneys. Structural characterization of extended globo-series compounds. Glyconjugate J 8: 424-433, 1991
20. Holgersson J, Backer AE, Breimer ME, Gustavsson ML, Jovall PA, Karlsson H, Pimlott W, Samuelsson BE: The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies. Biochim Biophys Acta 1180: 33-43, 1992
21. Seed PC, Hultgren SJ: Blueprinting the regulatory response of Escherichia coli to the urinary tract. Trends Microbiol 13: 246-248, 2005
22. Agace W, Hedges S, Andersson U, Andersson J, Ceska M, Svanborg C: Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun 61: 602-609, 1993
23. Hedges S, Svensson M, Svanborg C: Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 60: 1295-1301, 1992
24. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C: Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 183: 1037-1044, 1996
25. Frendeus B, Wachtler C, Hedlund M, Fischer H, Samuelsson P, Svensson M, Svanborg C: Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 40: 37-51, 2001
26. Rice JC, Peng T, Spence JS, Wang H-Q, Goldblum RM, Corthesy B, Nowicki BJ: Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney. J Am Soc Nephrol 16: 3583-3591, 2005
27. Greenwell D, Petersen J, Kulvicki A, Harder J, Goldblum R, Neal DE Jr: Urinary secretory immunoglobulin A and free secretory component in pyelonephritis. Am J Kidney Dis 26: 590-594, 1995
28. Soderhall M, Normark S, Ishikawa K, Karlsson K, Teneberg S, Winberg J, Mollby R: Induction of protective immunity after Escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor. J Clin Invest 100: 364-372, 1997